Related Experiment Video
Updated: Mar 23, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.6K
Validation of Computational Approaches for Antiretroviral Dose Optimization
Marco Siccardi1, Laura Dickinson2, Andrew Owen2
1Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom siccardi@liverpool.ac.uk.
Antimicrobial Agents and Chemotherapy
|April 6, 2016
Summary
Physiologically based modeling accurately predicted efavirenz pharmacokinetics, supporting reduced antiretroviral doses. This validated approach aids in optimizing HIV treatment and lowering drug costs for global access.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Computational Modeling in Pharmacology
- Global Health and Antiretroviral Therapy
Background:
- Reducing antiretroviral doses and costs is crucial for global access to HIV treatment.
- Efavirenz is a key antiretroviral medication, and dose optimization is an ongoing area of research.
Purpose of the Study:
- To validate a physiologically based pharmacokinetic (PBPK) model for efavirenz.
- To assess the feasibility of predicting efavirenz pharmacokinetics with reduced dosing regimens.
- To support strategies for lowering antiretroviral drug costs and improving global access.
Main Methods:
- A bottom-up physiologically based model was developed to simulate efavirenz pharmacokinetics.
- Simulation data were compared against clinical data from the ENCORE I trial.
- The trial compared efavirenz at 400 mg once daily versus 600 mg once daily.
Main Results:
- The PBPK model successfully predicted efavirenz pharmacokinetic data.
- The model demonstrated accuracy in simulating outcomes from dose reduction strategies.
- Findings support the use of 400 mg efavirenz as a viable alternative to 600 mg.
Conclusions:
- Validated computational models are pivotal for predicting pharmacokinetics under reduced dosing.
- PBPK modeling offers a valuable resource for optimizing therapeutic options in HIV treatment.
- This approach can facilitate cost-effective antiretroviral strategies and enhance global access to medicines.
Related Concept Videos
01:28Dosage Regimens: Designs and Approaches
453
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
453
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
341
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
341
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
301
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
301
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
368
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
01:10Retrovirus Life Cycles
50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
01:24Dosage Regimen: Individualization
279
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279